Here's how DOI.ORG makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

DOI . ORG {}

Detected CMS Systems:

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Doi.org Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. Hosting Providers
  13. CDN Services

We began analyzing https://journals.lww.com/hep/abstract/2013/04000/targeting_androgen_receptor_in_bone_marrow.28.aspx, but it redirected us to https://journals.lww.com/hep/abstract/2013/04000/targeting_androgen_receptor_in_bone_marrow.28.aspx. The analysis below is for the second page.

Title[redir]:
Hepatology
Description:
the BM-MSCs leading to unsatisfactory efficacy remains a major concern. Gender differences have been suggested in BM-MSCs therapeutic application, but the effect of the androgen receptor (AR), a key factor in male sexual phenotype, in this application is not clear. Using two liver cirrhosis mouse models induced by CCl4 or thioacetamide, we showed that targeting AR in the BM-MSCs improved their self-renewal and migration potentials and increased paracrine effects to exert anti-inflammatory and anti-fibrotic actions to enhance liver repair. Mechanism dissection studies suggested that knocking out AR in BM-MSCs led to improved self-renewal and migration by alteration of the signaling of epidermal growth factor receptor and matrix metalloproteinase 9 and resulted in suppression of infiltrating macrophages and hepatic stellate cell activation through modulation of interleukin (IL)1R/IL1Ra signaling. Therapeutic approaches using either AR/small interfering RNA or the AR degradation enhancer, ASC-J9®, to target AR in BM-MSCs all led to increased efficacy for liver repair.Conclusion: Targeting AR, a key factor in male sexual phenotype, in BM-MSCs improves transplantation therapeutic efficacy for treating liver fibrosis....

Matching Content Categories {📚}

  • Technology & Computing
  • Non-Profit & Charity
  • Telecommunications

Content Management System {📝}

What CMS is doi.org built with?


Doi.org is built with MYBB.

Traffic Estimate {📈}

What is the average monthly size of doi.org audience?

🏙️ Massive Traffic: 50M - 100M visitors per month


Based on our best estimate, this website will receive around 76,079,999 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Doi.org Make Money? {💸}

We're unsure if the website is profiting.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Doi.org could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

liver, bmmscs, aasld, transplantation, log, journal, efficacy, access, hepatology, subscribe, issue, alerts, abstract, targeting, receptor, cirrhosis, therapeutic, factor, clinical, disease, register, member, logo, browse, submit, androgen, bone, marrow, mesenchymal, stem, cells, therapy, buy, suggested, application, key, male, sexual, phenotype, improved, selfrenewal, migration, increased, led, signaling, copyright, american, association, study, diseases,

Topics {✒️}

aasld members log ar/small interfering rna bm-mscs therapeutic application replacing liver transplantation treat liver cirrhosis open access policy transplantation therapy efficacy liver cancer development treating liver fibrosis androgen receptor enhance liver repair individual subscribers log bm-mscs leading unsatisfactory efficacy remains institutional users access low survival rate male sexual phenotype exert anti-inflammatory anti-fibrotic actions artificial intelligence training bm-mscs improved bm-mscs led clinical trials irreversible disease increased paracrine effects liver diseases full text access ar degradation enhancer 1r/il1ra signaling liver repair journal tables register subscribe bm-mscs service request 800-638-3030 targeting ar therapeutic approaches increased efficacy journal key factor website subscribe alternative therapy target ar chiung-kuei1 soo ok1 kuo-pao1 wen-lung1 tzu-hua1 meng-yin3 eventually lead major concern

Questions {❓}

  • AASLD Member?
  • Not a Subscriber?

External Links {🔗}(68)

Analytics and Tracking {📊}

  • Comscore
  • Google Analytics
  • Google Tag Manager
  • Mouseflow

Libraries {📚}

  • Bootstrap
  • FontAwesome
  • jQuery
  • Video.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mx.zoho.eu
  • mx2.zoho.eu
  • mx3.zoho.eu

Name Servers:

  • josh.ns.cloudflare.com
  • zita.ns.cloudflare.com

CDN Services {📦}

  • Cookielaw
  • Jsdelivr
  • Mouseflow
  • Scite
  • Wolterskluwer

4.82s.